Cargando…

Parameters of Dynamic Contrast-Enhanced MRI as Imaging Markers for Angiogenesis and Proliferation in Human Breast Cancer

BACKGROUND: Breast cancer is the most common malignancy and the leading cause of cancer death in women worldwide; however, early diagnosis has been difficult due to its complex pathological structure. This study evaluated the value of morphological examination in conjunction with dynamic contrast-en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lin, Wang, Kai, Sun, Xilin, Wang, Kezheng, Sun, Yingying, Zhang, Guangfeng, Shen, Baozhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2015
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324575/ https://www.ncbi.nlm.nih.gov/pubmed/25640082 http://dx.doi.org/10.12659/MSM.892534

Ejemplares similares

Contrast agents in dynamic contrast-enhanced magnetic resonance imaging
por: Yan, Yuling, et al.
Publicado: (2017)

Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis
por: Kim, Sung Hun, et al.
Publicado: (2016)

DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin
por: Sun, Xilin, et al.
Publicado: (2016)

Correction: DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin
por: Sun, Xilin, et al.
Publicado: (2023)

Probing atherosclerotic angiogenesis with new manganese-based nanocolloid for T1-weighted MRI
por: Wang, Kezheng, et al.
Publicado: (2012)

Molecular Imaging of IGF-1R in Cancer
por: Sun, Yingying, et al.
Publicado: (2017)

In Vivo Monitoring of Angiogenesis Inhibition via Down-Regulation of Mir-21 in a VEGFR2-Luc Murine Breast Cancer Model Using Bioluminescent Imaging
por: Zhao, Dongliang, et al.
Publicado: (2013)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Xiao, Jennifer, et al.
Publicado: (2021)

Preoperative histogram parameters of dynamic contrast‐enhanced MRI as a potential imaging biomarker for assessing the expression of Ki‐67 in prostate cancer
por: Zhang, Yongsheng, et al.
Publicado: (2021)

Characteristics of quantitative perfusion parameters on dynamic contrast‐enhanced MRI in mammographically occult breast cancer
por: Ryu, Jung Kyu, et al.
Publicado: (2016)

MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn’s disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis
por: Bhatnagar, Gauraang, et al.
Publicado: (2016)

Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
por: Collet, Solène, et al.
Publicado: (2021)

Prevalence of Angiogenesis, Proliferation, and Apoptosis Markers of Cervical Cancer and Their Correlation with Clinicopathological Parameters
por: Ramesh, Anita, et al.
Publicado: (2020)

Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC
por: Xiao, Zunyu, et al.
Publicado: (2017)

Correlation Between Doppler Ultrasound Blood Flow Parameters and Angiogenesis and Proliferation Activity in Breast Cancer
por: Niu, Jiacheng, et al.
Publicado: (2019)

Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma
por: Jo, Sang Won, et al.
Publicado: (2021)

Dynamic contrast-enhanced MRI parameters and apparent diffusion coefficient as treatment response markers of skull base osteomyelitis: a preliminary study
por: Baba, Akira, et al.
Publicado: (2023)

Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules
por: Chen, Weizhi, et al.
Publicado: (2019)

Enhancement of Ovarian Malignancy on Clinical Contrast Enhanced MRI Studies
por: Pannu, Harpreet K., et al.
Publicado: (2013)

Protein O-glucosyltransferase 1 overexpression downregulates p16 in BT474 human breast cancer cells
por: JIN, GANG, et al.
Publicado: (2014)

Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma
por: Bharwani, N, et al.
Publicado: (2014)

Dynamic contrast‐enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases
por: Hatzoglou, Vaios, et al.
Publicado: (2017)

Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy
por: Reynolds, Hayley M., et al.
Publicado: (2022)

Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours
por: Checkley, D, et al.
Publicado: (2003)

Reproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan–Rescan Performance of Pharmacokinetic Parameters
por: Wang, Haiyi, et al.
Publicado: (2015)

Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients
por: Ulyte, Agne, et al.
Publicado: (2016)

Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI
por: Zhao, Weiwei, et al.
Publicado: (2018)

Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI
por: Ulas, Cagdas, et al.
Publicado: (2019)

Association between Dynamic Contrast-Enhanced MRI Parameters and Prognostic Factors in Patients with Primary Rectal Cancer
por: Kim, Hye Ri, et al.
Publicado: (2023)

Dynamic contrast enhanced (DCE) MRI estimation of vascular parameters using knowledge-based adaptive models
por: Bagher-Ebadian, Hassan, et al.
Publicado: (2023)

Quantitative dynamic contrast-enhance MRI parameters for rectal carcinoma characterization: correlation with tumor tissue composition
por: Yuan, Jie, et al.
Publicado: (2023)

Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI
por: Rodrigues, Filipe B., et al.
Publicado: (2019)

Application of Dynamic Contrast-Enhanced MRI in the Diagnosis of Rheumatoid Arthritis
por: Zhang, Bin, et al.
Publicado: (2022)

Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review
por: Han, Zhaoguo, et al.
Publicado: (2017)

Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases
por: Starck, Lea, et al.
Publicado: (2022)

Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer
por: Onishi, Natsuko, et al.
Publicado: (2020)

Diagnostic accuracy of dynamic contrast‐enhanced perfusion MRI in stratifying gliomas: A systematic review and meta‐analysis
por: Okuchi, Sachi, et al.
Publicado: (2019)

Assessment of therapeutic response in Crohn's disease using quantitative dynamic contrast enhanced MRI (DCE-MRI) parameters: A preliminary study
por: Zhu, Jianguo, et al.
Publicado: (2017)

Dynamics of angiogenesis and cellularity in rabbit VX2 tumors using contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging
por: Li, Haixia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g1qk0dkg8cg2es9e1r2q1mhfek